Cognetivity Neurosciences (XCNQ:CGN) Change In Payables And Accrued Expense : C$-0.96 Mil (TTM As of Oct. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Cognetivity Neurosciences Change In Payables And Accrued Expense?

Cognetivity Neurosciences's Change In Payables And Accrued Expense for the quarter that ended in Oct. 2023 was C$0.73 Mil. It means Cognetivity Neurosciences's Accounts Payable & Accrued Expense increased by C$0.73 Mil from Jul. 2023 to Oct. 2023 .

Cognetivity Neurosciences's Change In Payables And Accrued Expense for the fiscal year that ended in Jan. 2023 was C$0.06 Mil. It means Cognetivity Neurosciences's Accounts Payable & Accrued Expense increased by C$0.06 Mil from Jan. 2022 to Jan. 2023 .

Cognetivity Neurosciences Change In Payables And Accrued Expense Historical Data

The historical data trend for Cognetivity Neurosciences's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cognetivity Neurosciences Change In Payables And Accrued Expense Chart

Cognetivity Neurosciences Annual Data

Trend

Jan17

Jan18

Jan19

Jan20

Jan21

Jan22

Jan23

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

-0.13

0.57

0.07

5.83

0.06

Cognetivity Neurosciences Quarterly Data
	Jan19	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															1.91	-0.78	-0.87	-0.04	0.73

Cognetivity Neurosciences Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Oct. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.96 Mil.

Cognetivity Neurosciences Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Cognetivity Neurosciences's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Cognetivity Neurosciences (XCNQ:CGN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Cognetivity Neurosciences Ltd (XCNQ:CGN) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

CGNSF:USA 1UB:Germany

Address

800 West Pender Street, Suite 1430, Vancouver, BC, CAN, V6C 2V6

Website

https://www.cognetivity.com

Cognetivity Neurosciences Ltd is a technology company developing a cognitive testing platform, the Integrated Cognitive Assessment (ICA), for use in medical, commercial, and consumer environments for potentially allowing early diagnosis of dementia. The Company is considered operating in one segment for development of the ICA platform. Its geographical areas include Canada, United Kingdom and Dubai.

Cognetivity Neurosciences (XCNQ:CGN) Headlines

No Headlines